LeMaitre Will Announce Third Quarter 2021 Earnings Results on October 28, 2021
LeMaitre Vascular, Inc. (LMAT) will announce its Q3 2021 financial results on October 28, 2021, following the market's close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre Vascular, Inc. (LMAT) will announce its Q3 2021 financial results on October 28, 2021, following the market's close. A conference call is scheduled for 5:00 PM ET that same day to discuss the results and company outlook. The call can be accessed by dialing 844-239-5284 (international: +1-512-961-6497) and is available via a webcast at www.lemaitre.com/investor. LeMaitre provides vascular devices for treating peripheral vascular disease, serving a global market of over 200 million individuals.
Details
News Market Reaction – LMAT
The recorded move for LMAT in the trading session of this news was +0.15%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., Oct. 14, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2021 financial results on Thursday, October 28, 2021, after the market close. The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by dialing 844-239-5284 (+1-512-961-6497 for international callers), passcode 8308248. The call can also be accessed live or via replay through a webcast at www.lemaitre.com/investor.
About LeMaitre
LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.